Supplementary Figure S1 . Trend of KRT5 intensity per unit area of KRT5-positive pods in mouse infected lungs over time. Quantified by ImageJ software, the brightness intensity of KRT5 staining (in units per mm 2 ) increased from 9 dpi, reached a peak at 15 dpi, before decreasing until 25 dpi. At 25 dpi, the relatively large error bar was attributed to the absence of DASCs in one mouse. KRT5 expression was not detected in uninfected mouse lungs.
Supplementary
. Representative demarcation of the damaged area (DA), undamaged area (UA), and boundary area (BA) of a typical infected mouse lung at 13 dpi.
In the H&E section of infected lung, the DA is characterized by the loss of the normal alveolar architecture with negligible expression of PDPN, a marker of alveolar type I cells (A). Representative images of the boundary area between DA and UA at higher magnification of the area bounded by the white square (B -E).
Supplementary Figure S4 . DASCs are found only in the damaged area of infected lungs. We demarcated the infected mouse lungs as exemplified in this representative section at 13 dpi. DASCs with positive staining for KRT5 (and/or P63) were observed exclusively in the damaged area, but not in the undamaged area. No KRT5-positive expression was detected Supplementary Figure S5 . Proportion of DASCs in the total damaged area over time.
KRT5-positive DASCs began to appear at 11 dpi, attaining a maximum of 21% of the total damaged area at 21 dpi, before decreasing until 25 dpi. 5 7 9 1 1 1 3 1 5 1 7 1 9 2 1 2 3 2 5 (%) 5 7 9 1 1 1 3 1 5 1 7 1 9 2 1 2 3 2 5
Supplementary Figure S6 . Only a small fraction of KRT5-positive cells also co-express P63. We observed that only an average of 3-10% of the KRT5-positive cells also coexpressed the P63 marker.
Supplementary Figure S7 . About 1% or less of DASCs express the alveolar type I epithelial cell marker PDPN up to 25 dpi. For correlation with KRT5 and P63 staining of DASCs, the same lung sections in Figure 2 were subjected to staining for PDPN. Patchy PDPN staining was observed in lumens within the DASCs at 19 and 25 dpi. Notably, only about 1% or less of DASCs expressed PDPN. The positive control was represented by another undamaged area of the same lung section at 19 dpi, and showed widespread and strong PDPN staining as expected.
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Supplementary Figure S8 . DASCs do not express the Club cell marker CC10. No expression of CC10 was detected in the DASCs at 13, 19 and 25 dpi. The representative image at 13 dpi shows little to no CC10 staining in the area containing KRT5-positive DASC pods (which is encircled by the white dotted line). However, CC10 staining was detected in the lung area outside of the DASC pods (arrows).
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1 Supplementary Figure S9 . PDPN and CC10 are widely expressed in lungs of control mice subjected to mock infection with PBS. To authenticate the immunofluorescence staining for PDPN and CC10, lungs of uninfected mice were stained to detect these markers. As expected, there was widespread PDPN expression in the uninfected lungs (A). CC10 staining was localized in the bronchioles of uninfected lungs, where club cells reside (B). Bottom left insets depict higher magnification of the areas within the white squares.
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Supplementary Figure S10 . The distribution and organization of proliferating AT2 cells are distinct from DASCs. Based on their morphology by H&E staining, proliferating AT2 cells in infected lungs (circled in A, B, C) displayed enlarged and uncondensed nuclei similar to DASCs in pods (D), but expressed very low levels of KRT5 with absent P63 expression (C). However, DASCs differed by their pod-like organization as well as their close proximity to bronchioles (D). Hence, proliferating AT2 cells are likely to be a distinct cell population from DASCs. In control uninfected lungs at 7 days after mock infection, only a small number of these proliferating AT2 cells were detected (E).
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